Back to ressources
Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanisms
Legrier ME, Oudard S, Judde JG, Guyader C, de Pinieux G, Boye K, de Cremoux P, Dutrillaux B, Poupon MF.
Br J Cancer. (2007) Jan 29;96(2):269-76.
Read the publication
Discover
CTC-derived eXplants (CDX) offer systems for mechanistic investigation of CTC metastatic potency and may provide rationale for biology-driven therapeutics.
Discover
Discover
A preclinical platform of mouse-transplanted human pediatric liver tumors to evaluate the efficacy of conventional and innovative anticancer therapy
Discover
Discover
